why choose us

First received: May 29, 2023

Clinical Trial: UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Hematuria

Study Type: OBSERVATIONAL


Official Title: Hematuria Evaluation by Whole-genome Sequencing of Urine-Exfoliated Cell DNA, A Prospective, Multi-center Study

Brief Summary: Hematuria is recognized as an important sigh of potential urinary tract malignancy.Therefore, understanding the disease processes and discovering the potential urothelial carcinoma (UC) underlying this important sign is critical.Cystoscopy, urine cytology and imaging are most reliable methods for UC diagnosis, but certain drawbacks exist for these methods, such as invasiveness or inaccuracy.Chromosomal instability (CIN) is a hallmark of human cancer, and it's related with tumor stage and grade.Previous…

Read more